Latest Equity Raising News

Greenwing Resources reports solid progress across its lithium and graphite assets in Argentina, Madagascar, and Tasmania, completing a $3.5 million equity raise and appointing a new chairman.

Meteoric Resources has announced a maiden Ore Reserve at its Caldeira Project alongside a breakthrough processing partnership and a heavily oversubscribed $42.5 million equity raise, positioning it as a key player in the evolving rare earths market.

betr Entertainment Limited has boosted its all-scrip takeover offer for PointsBet while reporting a strong Q4 FY25 with $70 million EBITDA profit, underpinned by robust growth and strategic integrations.

American Rare Earths Limited reports strong progress at its Halleck Creek Rare Earths Project, highlighted by exceptional sampling results, key permitting milestones, and a $15 million equity raise to fund development.

Simble Solutions Limited reported a $527k equity raise and secured significant software contracts in Australia and the UK during Q2 FY25, while advancing its AI integration strategy amid a soft quarter.

Larvotto Resources has given the final nod to develop its Hillgrove Antimony-Gold Project in NSW, fully funded and moving into construction with production set for mid-2026.

FireFly Metals reports exceptional drilling results at its Green Bay Copper-Gold Project, extending mineralisation well beyond current resources. Backed by a substantial A$145 million capital raise, the company is poised for a resource update and advancing mining studies.

CuFe Ltd advances its Tennant Creek copper-gold project with a robust Orlando open pit scoping study and promising high-grade iron ore assays from Camp Creek, while exploring funding options to support ongoing development.

Enlitic reports a 48% revenue surge in Q2 FY25, secures a major $50 million partnership with GE HealthCare, and completes a $10 million equity raise, positioning itself for operational break-even by year-end.

Waratah Minerals has reported significant extensions of high-grade gold mineralisation at its Spur Gold-Copper Project, alongside promising porphyry copper-gold intersections at Breccia West. The company also secured $8.4 million in new equity to accelerate drilling activities.

Alterity Therapeutics has secured U.S. FDA Fast Track designation for its drug ATH434 targeting Multiple System Atrophy, supported by promising Phase 2 clinical trial data showing slowed disease progression and a solid safety profile.

Syrah Resources has resumed production at its Balama graphite mine after a year-long halt and is advancing sales at its US Vidalia anode material facility, supported by new US tariffs on Chinese imports and a $70 million equity raise.